Insider · CIK 0000938439

HALPRYN GLENN L

Reports to the SEC for 8 companies · MIAMI, FL

sec.gov

Transactions

Companies

Filings

CIK

0000938439

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-07-06	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)A Award	Director	AAward	+75K sh	—	—	339,309
2015-03-26	Castle Brands IncStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2014-03-05	Castle Brands IncStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2014-02-24	Castle Brands Inc10% Series A Convertible Preferred StockM Exercise/Conversion	Director	MExercise/Conversion	−209.192 sh	—	—	0
2014-02-24	Castle Brands IncM Exercise/Conversion	Director	MExercise/Conversion	+851K sh	$0.30	+$259K	1,194,900
2014-02-21	Castle Brands IncM Exercise/Conversion	Director	MExercise/Conversion	+344K sh	$0.38	+$131K	344,066
2014-02-21	Castle Brands IncCommon Stock Purchase WarrantsM Exercise/Conversion	Director	MExercise/Conversion	−344K sh	—	—	0
2014-01-21	NAGENiagen Bioscience, Inc.A Award	Director	AAward	+10K sh	—	—	10,000
2013-10-31	Castle Brands Inc5% Subordinated Convertible Note due 2018A Award	Director	AAward	—	$200000.00	—	—
2013-02-12	NAGENiagen Bioscience, Inc. · Warrants to Purchase Common StockX Exercise of In-Money	Director	XExercise of In-Money	−536K sh	—	—	0
2013-02-12	NAGENiagen Bioscience, Inc.X Exercise of In-Money	Director	XExercise of In-Money	+536K sh	$0.21	+$112K	1,271,428
2012-12-21	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)A Award	Director	AAward	+107K sh	—	—	189,309
2012-12-21	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−82.5K sh	—	—	165,000
2012-12-21	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−82.5K sh	—	—	82,500
2012-10-15	Castle Brands IncStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2012-08-28	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)A Award	Director	AAward	+82.5K sh	—	—	247,500
2012-02-10	NAGENiagen Bioscience, Inc.P Purchase	Director	PPurchase	+200K sh	$0.75	+$150K	735,714
2012-02-06	Sorrento Therapeutics, Inc.Non-qualified stock optionA Award	Director	AAward	+140K sh	—	—	140,000
2011-10-14	Castle Brands Inc10% Series A Convertible Preferred StockP Purchase	Director	PPurchase	+209.192 sh	$1000.00	+$209K	209.192
2011-10-14	Castle Brands IncCommon Stock Purchase WarrantsP Purchase	Director	PPurchase	+344K sh	—	—	344,066
2011-09-12	Castle Brands IncStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2011-05-10	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)A Award	Director	AAward	+82.5K sh	—	—	82,500
2011-04-15	Sorrento Therapeutics, Inc.Non-qualified stock optionA Award	Director	AAward	+7,500 sh	—	—	87,500
2010-11-29	Sorrento Therapeutics, Inc.Non-qualified stock optionA Award	Director	AAward	+30K sh	—	—	80,000
2010-05-20	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)A Award	Director	AAward	+82.5K sh	—	—	82,500
2010-05-20	NAGENiagen Bioscience, Inc. · Employee Stock Options (right to buy)A Award	Director	AAward	−82.5K sh	—	—	82,500
2010-02-05	Sorrento Therapeutics, Inc.Non-qualified stock optionA Award	Director	AAward	+10K sh	—	—	50,000
2010-02-04	Castle Brands IncStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2010-01-11	FLNTFluent, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2009-10-30	FLNTFluent, Inc.J Other	Director	JOther	+12.7K sh	—	—	12,668
2009-10-30	FLNTFluent, Inc.J Other	Director	JOther	+12.7K sh	—	—	12,688
2009-10-30	FLNTFluent, Inc. · WarrantJ Other	Director	JOther	+3,172 sh	—	—	3,172
2009-09-25	Winston Pharmaceuticals, Inc.Common Stock OptionsA Award	Director	AAward	+30K sh	—	—	30,000
2009-09-24	Winston Pharmaceuticals, Inc.Series B Convertible Preferred StockC Conversion	Director	CConversion	−229 sh	—	—	0
2009-09-24	Winston Pharmaceuticals, Inc.C Conversion	Director	CConversion	+229K sh	—	—	354,781
2009-09-21	Sorrento Therapeutics, Inc.Option to Purchase Common StockA Award	Director	AAward	+40K sh	—	—	40,000
2009-09-18	Sorrento Therapeutics, Inc.P Purchase	Director	PPurchase	+781K sh	$0.04	+$35K	781,102
2009-09-18	Sorrento Therapeutics, Inc.P Purchase	Director	PPurchase	+17.2M sh	$0.04	+$770K	17,184,228
2009-02-17	Castle Brands IncSeries A Convertible Preferred StockC Conversion	Director	CConversion	−80K sh	—	—	0
2009-02-17	Castle Brands IncC Conversion	Director	CConversion	+2.86M sh	—	—	2,857,144
2009-01-21	Castle Brands IncStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2008-09-25	Winston Pharmaceuticals, Inc.J Other	Director	JOther	+1.83M sh	—	—	2,839,534
2005-07-13	ERBA Diagnostics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Jul 74
ChromaDex Corp.0001415889-15-002335
SEC(opens sec.gov)
Mar 274
Castle Brands Inc0001209191-15-029880
SEC(opens sec.gov)
Mar 74
Castle Brands Inc0001209191-14-018351
SEC(opens sec.gov)
Feb 254
Castle Brands Inc0001209191-14-013733
SEC(opens sec.gov)
Jan 234
ChromaDex Corp.0001415889-14-000235
SEC(opens sec.gov)
Nov 44
Castle Brands Inc0001209191-13-050266
SEC(opens sec.gov)
Feb 134
HALPRYN GLENN L0001415889-13-000242
SEC(opens sec.gov)
Dec 264
HALPRYN GLENN L0001415889-12-001904
SEC(opens sec.gov)
Oct 174
HALPRYN GLENN L0001209191-12-049838
SEC(opens sec.gov)
Sep 254
HALPRYN GLENN L0001415889-12-001409
SEC(opens sec.gov)
Feb 144
HALPRYN GLENN L0001415889-12-000230
SEC(opens sec.gov)
Feb 74
HALPRYN GLENN L0001181431-12-006573
SEC(opens sec.gov)
Oct 174
HALPRYN GLENN L0001209191-11-051855
SEC(opens sec.gov)

Companies

Address

4400 BISCAYNE BOULEVARD SUITE 950

MIAMI, FL, 33137